Phase IIB Plasticity-based Adaptive Cognitive Remediation for Alzheimers Disease
Phase IIB Plasticity-based Adaptive Cognitive Remediation for Alzheimers Disease
批准号:
10603717
负责人:
Hyun Kyu Lee
金额:
$92.49万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-09-30 至 2026-01-31
关键词:
AdultAgeAge-associated memory impairmentAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAmericanAssessment toolBrainChronologyCognitionCognitiveCognitive remediationCollaborationsConduct Clinical TrialsDementiaDevelopmentDevicesEconomic BurdenEffectivenessElderlyEnrollmentEpidemiologyEvaluationFollow-Up StudiesFunctional Magnetic Resonance ImagingGoalsHomeHourImpaired cognitionIndividualInternetInterval trainingIowaLongevityMaintenanceMeasuresMediatingModelingMonitorNerve DegenerationNervous System PhysiologyNeuronal PlasticityOutcomeParticipantPathologyPerformancePharmacotherapyPhasePhase II Clinical TrialsPlayPopulationPreventionRandomizedScheduleSourceStandardizationStructureTestingTexasTherapeuticTimeTrainingTraining ProgramsUniversitiesactive controlage effectblood-based biomarkerbrain healthbrain volumecognitive abilitycognitive functioncognitive performancecognitive rehabilitationcognitive testingcognitive trainingcommercializationcomparative efficacycomputerizeddesignefficacy evaluationevidence basefollow up assessmentfollow-upimprovedinformation processingneurobehavioralnovelphase I trialphase II trialprocessing speedprogramsrecruitresiliencesocialstudy populationtoolwhite matter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary Abstract
The primary objectives of the current project are 1) to evaluate the longer-term efficacy of PACR-AD cognitive
training (PACR-CT) measured 5 years after the completion of initial 10 weeks of training, 2) to determine the
efficacy of the 10 weeks of booster training after 5 years from the initial training completion, and 3) to redesign
the PACR-CT for optimal training schedule to sustain and potentially further-grow program-delivered benefits.
We will examine prolonged PACR-CT efficacy compared to Active Control (Casual Games) at 5 years after
training by comparing 1) cognitive and functional performance, 2) structural (white matter integrity and brain
volume) and functional brain changes (rsfMRI and task-fMRI) and 3) neurodegeneration assessed with blood-
based biomarkers (pTau-181) predictive of AD risk. Next, we will examine the general booster efficacy (pre- vs.
post-booster training), and the interaction between initial training and booster training by comparing the change
scores between groups. Finally, we will modify PACR-CT schedule with the optimal booster training interval
calculated based on the rate of natural cognitive decline measured from Aim 1 and the performance
improvement from the 10 weeks of booster training from Aim 2. Evaluation of the longer-term effect PACR-CT
and the booster effect will be used to obtain FDA clearance for the program and commercialize it as the
evidence-based prevention device indicated for age-related cognitive decline. This project should result in the
development of a new, and powerful tool to provide effective adjunctive therapy that results in far greater
resilience against cognitive impairment in a substantially greater pre-AD population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Care Improving Cognition for ADolescents on the Autism Spectrum (CICADAS)
-
批准号:10266160
-
项目类别:
-
资助金额:$26.03万
-
财政年份:2020
-
负责人:Hyun Kyu Lee
-
依托单位:
Mobile cognitive control training for the treatment of Alcohol Use Disorder and Post Traumatic Stress Disorder
-
批准号:9409534
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2017
-
负责人:Hyun Kyu Lee
-
依托单位:
Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease
-
批准号:8715467
-
项目类别:
-
资助金额:$22.15万
-
财政年份:2014
-
负责人:Hyun Kyu Lee
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: